When coated with epitopes, BPs elicited DC-mediated MHC I and MHC II antigen presentation, CD4+ and CD8+ T cell priming resulting in differentiation into CTLs capable of mediating effective anti-tumour immunity. The gene discussed is CD4; the disease is neoplasm.